Physician profile
Stephen Sylvia
NPI 1891224390
$39,611.87
in general payments reported to CMS, 2019-2025
11 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $350 · 2021: $1,965 · 2022: $29K · 2023: $7,945 · 2024: $198 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,167 · Travel and Lodging: $2,178 · Food and Beverage: $1,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,166.67 |
| Travel and Lodging | $2,177.67 |
| Food and Beverage | $1,963.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,387.34 | 2022-2025 | |
| Smith+Nephew, INC. | $8,620.96 | 2022-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil |
| Djo, LLC | $2,500.00 | 2022 | |
| Kairos Surgical INC | $1,874.78 | 2021-2024 | |
| Encore Medical, Lp | $1,374.06 | 2023 | Djo Surgical |
| Medical Device Business Services, INC. | $1,338.96 | 2019-2022 | |
| Gemini Mountain Medical, LLC | $1,292.90 | 2022-2023 | |
| Stryker Corporation | $1,006.09 | 2019-2023 | Inspace, Blueprint Patient Specific Instrumentation, Mako |
| Pacira Therapeutics, INC. | $125.00 | 2019 | |
| Integra Lifesciences Corporation | $50.78 | 2021 | |
| Zimmer Biomet Holdings, INC. | $41.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sylvia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.